QUESTIONNAIRE AND FOLLOW-UP COMPUTER PROGRAM FOR PATIENTS WITH ENDOMETRIAL CANCER
Abstract
Background. Endometrial cancer is the most frequent genital malignancy among women in Slovenia. During diagnostic and treatment procedures as well as follow-up of endometrial cancer patients after treatment, a lot of data is generated. However, its amount frequently disable the transparency and instant availability.
Methods. An questionnaire for following of endometrial cancer patients has been compiled. Beside general information regarding the patient, diagnosis and treatment, it also includes the case history, data regarding clinical, ultrasonographic and preoperative examinations, surgery, histologic findings and follow-up after termination of treatment. A user-friendly computer program was developed for recording and processing of all available data collected during the diagnostic and treatment procedures.
Results. Questionnaire and computer program have been in use for three years and have found they are very useful in follow-up of patients with endometrial cancer. Data are collected at one site, transparent and always available. Statistical analysis of collected data can be performed by computer.
Conclusions. The aim of this uniform questionnaire and computer program is a concurrent, radical and simplified collecting and processing of data at each center dealing with the treatment of endometrial cancer.
Downloads
References
Gusberg SB. Diagnosis and principles of treatment of cancer of the endometrium. In: Gusberg SB, Shingleton HM, Deppe G eds. Female genital cancer. New York: Churchill, 1988: 337–60.
Cowan BD, Morrison JC. Management of abnormal genital bleeding in girls and women. N Engl J Med 1991; 324: 1710–5.
Golouh R, Lindtner J, Pompe-Kirn V et al. (eds.). Incidenca raka v Sloveniji 1999. Ljubljana: Onkološki inštitut, 2002: 30–44.
Stržinar V. Rak materničnega telesa. In: Fras AP ed. Onkologija. Ljubljana; Onkološki inštitut v Ljubljani, 1994: 300–4.
Pajntar M, Leskošek B. Rezultati projekta: »Kakovost v zdravstvu Slovenije«. Zdrav Vestn 2002; 71: 765–71.
Gehrig PA, Van Le L, Fowler WC. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer 2003; 13: 212–5.
Fras AP. Brahiterapija pri raku ženskih spolovil. In: Fras AP ed. Onkologija. Ljubljana; Onkološki inštitut v Ljubljani, 1994: 318–21.
Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer 1997; 79: 320–7.
Chambers JT, Rutherford TJ, Schwartz PE, Carcangiu ML, Chambers SK, Baker L. A pilot study of topotecan in the treatment of serous carcinoma of the uterus. Int J Gynecol Cancer 2003; 13: 216–22.
Lampe B, Kürzl R, Hantschmann P. Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage. Int J Gynecol Pathol 1995; 14: 2–6.
Hachisuga T, Kawarabayashi T, Iwasaka T, Sugimori H, Kamura T, Tsuneyoshi M. The prognostic value of semiquantitative nuclear grading in endometrial carcinomas. Gynecol Oncol 1997; 65: 115–20.
Matthews RP, Hutchinson-Colas J, Maiman M et al. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women. Gynecol Oncol 1997; 65: 206–12.
Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64: 411–7.
Reich O, Winter R, Pickel H, Tamussino K, Haas J, Petru E. Does the size of pelvic lymph nodes predict metastatic involvement in patients with endometrial cancer? Int J Gynecol Cancer 1996; 6: 445–7.
Creasman WT, Boronow RC, Morrow CP, Di Saia PJ, Blessing J. Adenocarcinoma of the endometrium: Its metastatic lymph node potential. Gynecol Oncol 1976; 4: 239–43.
Calais G, Descamps P, Vitu L et al. Is lymphadenectomy useful in the treatment of endometrial carcinoma? Gynecol Oncol 1990; 38: 71–5.
Lanciano RM, Greven KM. Adjuvant treatment for endometrial cancer: Who needs it? Gynecol Oncol 1995; 57: 135–7.
Watanabe M, Aoki Y, Kase H, Fujita K, Tanaka K. Low risk endometrial cancer: A study of pelvic lymph node metastasis. Int J Gynecol Cancer 2003; 13: 38–41.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
